Morning Market Movers
June 12, 2014 at 09:38 AM EDT
Zalicus (NASDAQ: ZLCS) shares climbed 50% to $1.62 on Epirus report that Phase 3 data demonstrated comparability of BOW015 to remicade ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.